Fortive Corporation designs, develops, manufactures, and services professional and engineered products, software, and services in the United States, China, and internationally. It operates in three segments: Intelligent Operating Solutions, Precision Technologies, and Advanced Healthcare Solutions. The Intelligent Operating Solutions segment provides advanced instrumentation, software, and services, including electrical test and measurement, facility and asset lifecycle software applications, and connected worker safety and compliance solutions for manufacturing, process industries, healthcare, utilities and power, communications and electronics, and other industries. This segment markets its products and services under the ACCRUENT, FLUKE, GORDIAN, INDUSTRIAL SCIENTIFIC, INTELEX, PRUFTECHNIK, and SERVICECHANNEL brand names. The Precision Technologies segment offers electrical test and measurement, sensing and material technologies for industrial, power and energy, automotive, medical equipment, food and beverage, aerospace and defense, semiconductor, and other general industries under the ANDERSON-NEGELE, GEMS, SETRA, HENGSTLER-DYNAPAR, QUALITROL, PACIFIC SCIENTIFIC, KEITHLEY, and TEKTRONIX brand names. The Advanced Healthcare Solutions segment provides critical workflow solutions comprising instrument sterilization, instrument tracking, design and manufacture of cell therapy equipment, biomedical test tools, radiation detection and safety monitoring, and end-to-end clinical productivity software and solutions under the ASP, CENSIS, CENSITRAC, EVOTECH, FLUKE BIOMEDICAL, INVETECH, LANDAUER, PROVATION, RAYSAFE, and STERRAD brand names. Fortive Corporation was incorporated in 2015 and is headquartered in Everett, Washington.

Fortive Corporation

Citi analyst Andrew Kaplowitz maintained a Hold rating on Fortive today and set a price target of $59.00. Kaplowitz covers the Industrials sector, ...

Fortive (FTV) Receives a Hold from Citi

Foresight Vct ( ($GB:FTV) ) has issued an announcement. Foresight VCT PLC announced that as of November 28, 2025, its issued share capital consiste...

Current Quarter	$0.84	Next Quarter	$0.62
Current Year	$2.64	Next Year	$2.81
QoQ Growth	-26.2%	YoY Growth	+6.4%
3Y EPS CAGR	+13.4%	Target Price	$56.50
Consensus	Buy	Upside	+2.9%

Current Quarter Rev	N/A	Next Quarter Rev	N/A
Revenue Growth	N/A	YoY Growth	N/A

	A	B	C	D
1	Symbol	Price	Change	Volume
2	FTV	$54.93	-0.96%	3.05M
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	FTV	$54.93	-1.0%	3.05M
3
4
5
6

FTV

FTV

EPS Estimates Overview

EPS Historical Trend (5 Years)

Quarterly EPS Estimates

Revenue Analysis

Get Fortive Corporation Data in Excel

Get Fortive Corporation Data in Excel